CrystalsFirst logo

CrystalsFirst

Turning Insights Into Medicines

18 employees · est. 2018 · Hamburg, Germany

VS
Genesis Molecular AI logo

Genesis Molecular AI

Unifying AI and Biotech to accelerate the discovery of new medicines

162 employees · est. 2019 · Burlingame, United States

CrystalsFirst is the older company (2018 vs 2019); Genesis Molecular AI is the larger of the two.

Side-by-Side Comparison

CrystalsFirst Genesis Molecular AI
Founded
2018 older 2019
Headquarters
Hamburg, Germany Burlingame, United States
Employees
18 162 larger
Industry
AI, Biotechnology, Health Care AI, Biotechnology, Information Technology
Funding Stage
Non Equity Assistance Unknown
Total Funding
$756.60K $280.13M
Funding Rounds
4 5
Services
Not tracked yet AI Research and Development, Molecular Design AI Platform, Drug Discovery Solutions, Pharma Partnership Programs
Target Customers
Not tracked yet Pharmaceutical Companies, Biotech Researchers, Medical Research Institutions, Drug Development Teams
Taxonomy
Drug Discovery, Structural Biology, Computational Modelling, Generative AI, Medicinal Chemistry, Crystal Structure, Target Interactions, Rational Design, Hit Expansion, Scaffold Hopping, Compound Generation, Therapeutic Compounds, Innovative Technology, Pharmaceutical Research Molecular AI, Drug Discovery, Generative AI, Predictive Modelling, Biophysics, Pharmaceuticals, Generative Diffusion Model, Lead Optimization, AI-enabled Drug Design, Biotech Collaborations, Deep Neural Networks, Chemical Synthesis Optimization, Undruggable Targets
Website
crystalsfirst.com genesistherapeutics.ai
CrystalsFirst logo

About CrystalsFirst

CrystalsFirst is a biotechnology startup with the slogan "Turning Insights Into Medicines." Founded in 2018 and headquartered in Germany, the company is focused on revolutionizing small molecule drug discovery through its proprietary MAGNET platform. This technology integrates structural biology, ge...

Genesis Molecular AI logo

About Genesis Molecular AI

Genesis Molecular AI, founded in 2019 and headquartered in the United States, is advancing the intersection of AI and Biotechnology to expedite new medicine discovery. The company’s proprietary platform, GEMS (Genesis Exploration of Molecular Space), leverages leading-edge generative and predictive...

We will tell you when either one moves

BounceWatch watches CrystalsFirst and Genesis Molecular AI for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at CrystalsFirst and Genesis Molecular AI — by email.

Frequently Asked Questions

CrystalsFirst — Turning Insights Into Medicines. Genesis Molecular AI — Unifying AI and Biotech to accelerate the discovery of new medicines. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
CrystalsFirst has raised $756.60K while Genesis Molecular AI has raised $280.13M.
CrystalsFirst and Genesis Molecular AI operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare CrystalsFirst with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at CrystalsFirst on 12 Sep 2024, and Genesis Molecular AI on 24 Aug 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy